Loading...
XLON
NANO
Market cap6mUSD
Jul 09, Last price  
2.50GBP
1D
-9.75%
1Q
-47.81%
Jan 2017
-94.44%
IPO
-95.08%
Name

Nanoco Group PLC

Chart & Performance

D1W1MN
XLON:NANO chart
P/E
P/S
0.60
EPS
Div Yield, %
Shrs. gr., 5y
-6.03%
Rev. gr., 5y
14.59%
Revenues
8m
-3.25%
14,00082,0001,078,0001,994,0002,937,0002,642,0002,948,0003,928,0001,433,0002,029,000474,0001,326,0003,315,0007,123,0003,856,0002,091,0002,467,0005,618,0007,874,0007,618,000
Net income
-2m
L+75.34%
-11,827,000-1,763,000-551,000-540,000-1,083,000-2,492,000-3,640,000-4,122,000-7,811,000-8,975,000-10,607,000-9,110,000-6,005,000-4,358,000-5,079,000-4,395,000-4,697,00011,085,000-1,253,000-2,197,000
CFO
-5m
L
-12,017,000-3,260,000-682,000-132,000-28,000-1,338,000-1,373,000-4,305,000-6,638,000-7,550,000-8,860,000-7,821,000-340,000-612,000-3,531,000-3,360,000-1,780,000-27,840,00051,479,000-4,866,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Nanoco Group plc, along with its subsidiaries, specializes in the innovation, production, and commercialization of advanced nanoscale materials tailored for a diverse range of commercial sectors. Its product portfolio features CFQD quantum dots, which are fluorescent semiconductor nanoparticles utilized for applications such as OLED and µLED color conversion, quantum dot electroluminescence (QD-EL), and security tagging. Further offerings include HEATWAVE quantum dots, designed for the sensor industry, and VIVODOTS nanoparticles, specifically engineered for medical and veterinary applications. The company maintains a significant international footprint, with operations extending across the United Kingdom, Japan, Singapore, Holland, France, Taiwan, Canada, Saudi Arabia, and the United States. Established in 2001, Nanoco Group plc is headquartered in Runcorn, UK, having previously traded as Evolutec Group plc before rebranding to its current name in April 2009.
IPO date
May 01, 2009
Employees
36
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑072024‑072023‑072022‑072021‑072020‑072019‑072018‑072017‑072016‑07
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT